Lidocaine Numbing Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Lidocaine Numbing Cream
Generic name: LIDOCAINE
Manufacturer: KORVIA GLOBAL Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 5690db03-4d62-9660-e063-6394a90a2fc0
SPL ID: 5690da8b-0423-7cb4-e063-6294a90a1b1b
Version: 1
Effective date: 2026-07-14
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:48:12

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Lidocaine Numbing Cream	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		KORVIA GLOBAL Inc.	openfda.manufacturer_name
ndc	package	87253-311-01	openfda.package_ndc
ndc	product	87253-311	openfda.product_ndc
ndc11	package	87253031101	derived:openfda.package_ndc
rxcui		1366789	openfda.rxcui
spl id		5690da8b-0423-7cb4-e063-6294a90a1b1b	id
spl set id		5690db03-4d62-9660-e063-6394a90a2fc0	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Allergy alert : Certain persons can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase, discontinue use and consult a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.